About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphadenectomy in NSCLC With and Without Adjuvant Therapy

Lymphadenectomy in NSCLC With and Without Adjuvant Therapy

NCT04419935·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Informed consent
Age \>18 years
Non-Small Cell Lung Cancer Histology
Anatomical lung resection (segmentectomy, lobectomy or bilobectomy, pneumonectomy)
Pre-operative CT and PET evaluation
Preoperative and postoperative tumour board discussion
Intraoperative lymph node assessment (minimum 3 mediastinal stations harvested)
Lymph node metastases

You may not be if

AGE \< 18 years
Pregnancy
Psychiatric disease
Wedge resection
Distant metastases

The record

StatusUnknown

PhaseNo phase

Taking part250

StartedMay 2020

UpdatedJun 9, 2020

Conditions

NSCLC Lymph Node Metastases

Where1

Marco Chiappetta
Roma, Italy